when will there be a generic tirzepatide FDA Accepts Sandoz Applications for Generic Tirzepatide: When It Could
Description
Magnitude of weight loss Phase 2 clinical trial results published in The New England journal of medicine suggest retatrutide may prompt even greater weight loss than other weight-loss medications, including Zepbound
This mechanism shift explains why Retatrutide produces weight loss through two distinct pathways
Generic alternatives typically become available only after patent expiration and FDA approval of abbreviated new drug applications (ANDAs), a process that may take several years from the original approval date
Diabetes Care 2025;48:1622-7
